ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
다우존스 지수
39,069.59
0.01%
Bitcoin
69,326.08
1.19%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Rani Therapeutics Holdings Inc (RANI)

  7. Rani Therapeutics Holdings Inc (RANI) 뉴스

RANI

Rani Therapeutics (RANI)

Rani Therapeutics Holdings Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:RANI
일자시간출처헤드라인심볼기업
2024/05/1421:00GlobeNewswire Inc.Rani Therapeutics to Participate in May Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
2024/05/0921:00GlobeNewswire Inc.Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024NASDAQ:RANIRani Therapeutics Holdings Inc
2024/05/0705:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RANIRani Therapeutics Holdings Inc
2024/05/0705:05GlobeNewswire Inc.Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
2024/05/0705:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
2024/03/2105:05GlobeNewswire Inc.Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
2024/03/1605:05GlobeNewswire Inc.Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:RANIRani Therapeutics Holdings Inc
2024/02/0522:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
2024/02/0522:00GlobeNewswire Inc.Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)NASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/2006:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/2006:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/2006:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/2006:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/2006:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/2006:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/2006:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/1422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/1422:00GlobeNewswire Inc.Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin TriagonistNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/0807:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/0622:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
2023/12/0122:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
2023/11/0906:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RANIRani Therapeutics Holdings Inc
2023/11/0906:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
2023/11/0906:05GlobeNewswire Inc.Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
2023/11/0205:05GlobeNewswire Inc.Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill® Technology Platform; Reports Preliminary Third QuNASDAQ:RANIRani Therapeutics Holdings Inc
2023/11/0205:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
2023/10/2521:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
2023/10/2521:00GlobeNewswire Inc.The RaniPill® Capsule, Rani Therapeutics’ Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety StudyNASDAQ:RANIRani Therapeutics Holdings Inc
2023/10/2005:05GlobeNewswire Inc.Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical StudyNASDAQ:RANIRani Therapeutics Holdings Inc
2023/10/1305:05GlobeNewswire Inc.Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral ResearchNASDAQ:RANIRani Therapeutics Holdings Inc
 검색 관련기사 보기:NASDAQ:RANI

최근 히스토리

USOTC
VXIT
Virexit Technologies (PK)
LSE
2SZM
Zoom 2xs $
NYSE
TCRX
THL Credit, Inc.
COIN
XMRETH
Monero
COIN
SWZLUST
SwapZilla
AMEX
IXG
iShares Global Financials
BIT
UB3560
UniCredit Bank
USOTC
RTLGF
St Augustine Gold and Co... (PK)
TSXV
ROR
HUOB
MUUSDT
Miracle Universe
UNSW
LCSETH
LocalCoinSwap Cryptoshare
COIN
TZKIUST
Tsuzuki Inu
EU
BN15B
Bnp Paribas null
BIT
F17921
Vontobel Financial Produ...
AMEX
EWG
IShares MSCI Germany
USOTC
IPUB
IndiePub Entertainment (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유